$1.71
0.58%
Downside
Day's Volatility :7.1%
Upside
6.56%
26.32%
Downside
52 Weeks Volatility :67.44%
Upside
55.81%
Period | Xwell Inc | Index (Russel 2000) |
---|---|---|
3 Months | 9.62% | 0.0% |
6 Months | -14.5% | 0.0% |
1 Year | -54.76% | 0.0% |
3 Years | -87.57% | -22.3% |
Market Capitalization | 9.3M |
Book Value | $2.1 |
Earnings Per Share (EPS) | -5.02 |
Wall Street Target Price | 7.0 |
Profit Margin | -63.9% |
Operating Margin TTM | -20.19% |
Return On Assets TTM | -16.02% |
Return On Equity TTM | -76.23% |
Revenue TTM | 32.9M |
Revenue Per Share TTM | 7.86 |
Quarterly Revenue Growth YOY | 13.5% |
Gross Profit TTM | 12.0M |
EBITDA | -10.6M |
Diluted Eps TTM | -5.02 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 309.36%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 50.1M | ↑ 2.6% |
Net Income | -37.2M | ↑ 29.0% |
Net Profit Margin | -74.27% | ↓ 15.2% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 48.5M | ↓ 3.15% |
Net Income | -20.5M | ↓ 44.82% |
Net Profit Margin | -42.32% | ↑ 31.95% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 8.4M | ↓ 82.72% |
Net Income | -92.2M | ↑ 349.25% |
Net Profit Margin | -1.1K% | ↓ 1057.64% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 73.7M | ↑ 779.3% |
Net Income | 3.3M | ↓ 103.63% |
Net Profit Margin | 4.54% | ↑ 1104.5% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 55.9M | ↓ 24.13% |
Net Income | -32.6M | ↓ 1074.29% |
Net Profit Margin | -58.33% | ↓ 62.87% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 30.1M | ↓ 46.18% |
Net Income | -27.7M | ↓ 14.98% |
Net Profit Margin | -92.14% | ↓ 33.81% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.6M | ↑ 0.0% |
Net Income | -14.3M | ↑ 5.97% |
Net Profit Margin | -188.69% | ↓ 10.64% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 8.2M | ↑ 8.16% |
Net Income | -5.7M | ↓ 59.82% |
Net Profit Margin | -70.09% | ↑ 118.6% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.5M | ↓ 8.65% |
Net Income | -9.9M | ↑ 73.09% |
Net Profit Margin | -132.81% | ↓ 62.72% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.4M | ↓ 0.87% |
Net Income | -6.6M | ↓ 33.62% |
Net Profit Margin | -88.94% | ↑ 43.87% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 8.7M | ↑ 17.87% |
Net Income | -2.5M | ↓ 61.85% |
Net Profit Margin | -28.79% | ↑ 60.15% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 9.3M | ↑ 6.37% |
Net Income | -2.0M | ↓ 20.54% |
Net Profit Margin | -21.5% | ↑ 7.29% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 30.6M | ↓ 53.12% |
Total Liabilities | 17.4M | ↓ 10.06% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 28.7M | ↓ 6.08% |
Total Liabilities | 31.3M | ↑ 79.15% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 103.1M | ↑ 259.05% |
Total Liabilities | 22.8M | ↓ 27.18% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 127.3M | ↑ 23.4% |
Total Liabilities | 27.3M | ↑ 20.07% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 70.4M | ↓ 44.66% |
Total Liabilities | 22.5M | ↓ 17.76% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 39.0M | ↓ 44.63% |
Total Liabilities | 18.0M | ↓ 19.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 70.4M | ↑ 0.0% |
Total Liabilities | 22.5M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 56.6M | ↓ 19.65% |
Total Liabilities | 19.6M | ↓ 12.86% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 44.6M | ↓ 21.27% |
Total Liabilities | 17.3M | ↓ 11.78% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 39.0M | ↓ 12.47% |
Total Liabilities | 18.0M | ↑ 4.29% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 37.5M | ↓ 3.89% |
Total Liabilities | 18.7M | ↑ 3.83% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 36.3M | ↓ 3.17% |
Total Liabilities | 19.1M | ↑ 1.87% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -6.6M | ↓ 46.06% |
Investing Cash Flow | -1.9M | - |
Financing Cash Flow | 5.6M | ↓ 7.28% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -113.0K | ↓ 98.28% |
Investing Cash Flow | -2.3M | ↑ 21.92% |
Financing Cash Flow | 1.2M | ↓ 79.36% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -25.0M | ↑ 22034.51% |
Investing Cash Flow | -4.3M | ↑ 91.16% |
Financing Cash Flow | 117.2M | ↑ 9962.23% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 15.6M | ↓ 162.54% |
Investing Cash Flow | -5.2M | ↑ 18.56% |
Financing Cash Flow | 6.3M | ↓ 94.58% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -24.2M | ↓ 254.63% |
Investing Cash Flow | -34.8M | ↑ 575.78% |
Financing Cash Flow | -27.4M | ↓ 531.2% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -6.8M | ↑ 0.0% |
Investing Cash Flow | -3.3M | ↓ 86.24% |
Financing Cash Flow | 279.0K | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.8M | ↓ 59.41% |
Investing Cash Flow | -480.0K | ↓ 85.41% |
Financing Cash Flow | -120.0K | ↓ 143.01% |
Sell
Neutral
Buy
Xwell Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Xwell Inc | -29.05% | -14.5% | -54.76% | -87.57% | -87.57% |
![]() Idexx Laboratories, Inc. | 1.13% | -16.13% | -1.02% | -30.71% | 76.78% |
![]() Agilent Technologies Inc. | 2.42% | -8.11% | 18.01% | -22.8% | 84.96% |
![]() Thermo Fisher Scientific, Inc. | 4.08% | 2.29% | 14.99% | 7.41% | 109.35% |
![]() Danaher Corp. | 1.1% | 4.75% | 17.79% | -19.33% | 91.02% |
![]() Iqvia Holdings Inc. | 5.86% | -6.0% | 10.99% | -8.08% | 60.05% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Xwell Inc | NA | NA | NA | 0.0 | -0.76 | -0.16 | NA | 2.1 |
![]() Idexx Laboratories, Inc. | 46.49 | 46.49 | 5.05 | 10.51 | 0.63 | 0.23 | NA | 19.16 |
![]() Agilent Technologies Inc. | 28.76 | 28.76 | 2.99 | 5.24 | 0.25 | 0.08 | 0.01 | 20.53 |
![]() Thermo Fisher Scientific, Inc. | 37.6 | 37.6 | 2.26 | 21.75 | 0.14 | 0.05 | 0.0 | 124.17 |
![]() Danaher Corp. | 48.58 | 48.58 | 2.63 | 7.58 | 0.08 | 0.04 | 0.0 | 68.92 |
![]() Iqvia Holdings Inc. | 32.24 | 32.24 | 1.22 | 11.2 | 0.23 | 0.05 | NA | 36.83 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Xwell Inc | Buy | $9.3M | -87.57% | NA | -63.9% |
![]() Idexx Laboratories, Inc. | Buy | $38.9B | 76.78% | 46.49 | 22.34% |
![]() Agilent Technologies Inc. | Buy | $39.8B | 84.96% | 28.76 | 21.75% |
![]() Thermo Fisher Scientific, Inc. | Buy | $233.5B | 109.35% | 37.6 | 14.69% |
![]() Danaher Corp. | Buy | $192.3B | 91.02% | 48.58 | 17.83% |
![]() Iqvia Holdings Inc. | Buy | $45.2B | 60.05% | 32.24 | 9.39% |
Insights on Xwell Inc
Revenue is up for the last 3 quarters, 7.40M → 9.28M (in $), with an average increase of 10.6% per quarter
Netprofit is up for the last 4 quarters, -9.91M → -1.99M (in $), with an average increase of 79.5% per quarter
In the last 1 year, Agilent Technologies Inc. has given 18.0% return, outperforming this stock by 72.8%
BlackRock Inc
Vanguard Group Inc
Geode Capital Management, LLC
State Street Corporation
Susquehanna International Group, LLP
Integrated Wealth Concepts LLC
xpresspa group, inc. (nasdaq:xspa) is a health and wellness holding company. xpresspa group’s core asset, xpresspa, is the world’s largest airport spa company, with 57 locations in 23 airports globally (as of january 8, 2018), including one off-airport spa at westfield world trade center in new york city. xpresspa offers services that are tailored specifically to the busy customer. xpresspa is committed to providing exceptional customer experiences with its innovative premium spa services, as well as exclusive luxury travel products and accessories. xpresspa serves almost one million customers per year at its locations in the united states, holland, and the united arab emirates. xpresspa group’s non-core assets include group mobile, infomedia, and an intellectual property assets. to learn more about xpresspa group, visit: www.xpresspagroup.com. to learn more about xpresspa, visit www.xpresspa.com.
Organization | Xwell Inc |
Employees | 266 |
CEO | Mr. Scott R. Milford |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$1.71
-3.39%
Keyarch Acquisition Corp
$1.71
-3.39%
Connexa Sports Technologies Inc
$1.71
-3.39%
Us Value Etf
$1.71
-3.39%
First Wave Biopharma Inc
$1.71
-3.39%
Global X Msci Next Emerging
$1.71
-3.39%
Fat Projects Acquisition Corp
$1.71
-3.39%
Capital Link Global Fintech
$1.71
-3.39%
Applied Uv Inc
$1.71
-3.39%